BETHESDA, MdTo increase the number of cancer patients
participating in phase III clinical trials, the National Cancer
Institute has created the Expanded Participation Project (EPP). This
pilot program encourages qualified oncologists outside of the 12
NCI-sponsored Cooperative Groups to enter patients into large
clinical studies organized by groups.
Under EPP, qualified oncologists can enter patients in 16 large
clinical trials for breast, lung, prostate, and colorectal cancer.
Other phase III trials will be opened up to EPP participating
physicians later this year.
The program offers a simplified, Internet-based process for enrolling
patients and a direct reimbursement of $1,500 per patient to
physicians to cover their research-related time and costs.
NCI expects EPP to become a national program that will significantly
reduce the time it takes to accrue the hundreds or thousands of
patients necessary for phase III studies. Additional information is
available on the EPP website located at http://light.emmes.com/epp